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A B S T R A C T
The aim of the study was to estimate the consumption of antibiotic in ambulatory
care. Oral antibiotic consumption in 1999 was analyzed in four pharmacies in the
Zagreb area. The use of oral antibiotics in comparison with total drug consumption, the
share of individual subclasses of oral antibiotics and the respective shares of individual
products were also analyzed. The results obtained were expressed in terms of both the
defined daily doses (DDD) and US$, and were compared with available national and
international data. The study demonstrated a high share of oral antibiotics in the over-
all drug consumption, especially of newer and more expensive agents within individual
subclasses of antibiotics. Further research is required to assess the rationale of such pre-
scribing practices, especially in view of the current financial pressure on the Croatian
health care system.
Introduction
The governments of all countries, de-
veloped and developing alike make enor-
mous efforts to rationalize health care
provision and disease management with
the aim of optimizing their respective
health care systems.
As one of the most widely prescribed
groups of drugs, antibiotics have been the
topic of numerous medical and economic
studies because of the relatively rapid
emergence of bacterial resistance one the
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ORAL ANTIBIOTIC CONSUMPTION IN ZAGREB IN 1999
PHARMACY 1 PHARMACY 2 PHARMACY 3 PHARMACY 4
ANTIBIOTIC DDD % $ % DDD % $ % DDD % $ % DDD % $ %
PENICILLINS 18260 55.67 15893.11 46.25 8633 50.26 7994.48 40.61 25443 68.44 18190.42 54.96 13948 49.70 12730.05 36.16
benzylpenicillin 4535 24.84 2134.51 13.43 1574 18.23 636.40 7.96 4225 16.61 2168.12 11.92 2400 17.21 1146.76 9.01
ampicilin 89 0.49 63.03 0.40 160 1.85 106.18 1.33 92 0.36 76.36 0.42 96 0.69 8.11 0.06
amoxicilin 6812 37.31 2387.53 15.02 3174 36.77 1107.27 13.85 14585 57.32 5178.71 28.47 3874 27.77 1357.28 10.66
amox/clav.acid 6824 37.37 11308.04 71.15 3725 43.15 6144.63 76.86 6541 25.71 10767.22 59.19 7578 54.33 10217.90 80.27
CEPHALOSPORINS 4321 13.17 8182.90 23.81 2182 12.70 4706.02 23.90 3760 10.11 7489.09 22.63 4080 14.54 11680.84 33.18
cephalexin 3193 73.89 4207.83 51.42 1299 59.53 1701.57 36.16 2704 71.91 3685.71 49.21 1916 46.96 2523.13 21.60
cefuroxime axetil 854 19.76 3160.97 38.63 663 30.38 2351.57 49.97 840 22.34 3162.02 42.22 1274 31.23 6519.65 55.81
ceftibuten 274 6.34 814.11 9.95 220 10.08 652.88 13.87 216 5.74 641.37 8.56 890 21.81 2638.06 22.58
MACROLIDES 2356 7.18 6198.63 18.04 1753 10.21 4654.89 23.64 1824 4.91 4535.77 13.70 2352 8.38 6188.83 17.58
erythromycin 180 7.64 181.36 2.93 112 6.39 112.85 2.42 312 17.11 314.34 6.93 172 7.31 116.90 1.89
azythromycin 21.76 0.92 6017.27 97.07 1641 93.61 4542.05 97.58 1512 82.89 4221.43 93.07 2180 92.69 6071.93 98.11
TETRACYCLINES 3135 9.56 409.93 1.19 1458 8.49 190.65 0.97 2022 5.44 264.39 0.80 2809 10.01 367.30 1.04
doxycycline 3135 100.00 409.93 100.00 1458 100.00 190.65 100.00 2022 100.00 264.39 100.00 2809 100.00 367.30 100.00
QUINOLONES 2417 7.37 2809.36 8.18 1250 7.28 1516.94 7.71 1550 4.17 1780.55 5.38 2405 8.57 3309.12 9.40
norfloxacin 2380 98.47 2724.36 96.97 1200 96.00 1373.62 90.55 1540 99.35 1762.66 99.00 1840 76.51 2106.14 63.65
ciprofloxacin 22 0.91 58.45 2.08 40 3.20 125.53 8.28 0 0.00 0.00 0.00 150 6.24 467.20 14.12
pefloxcin 15 0.62 26.54 0.94 10 0.80 17.78 1.17 10 0.65 17.78 1.00 415 17.26 735.78 22.23
CO-TRIMOXAZOLE 2103 6.41 601.49 1.75 1810 10.54 506.95 2.58 2485 6.68 711.72 2.15 2274 8.10 673.80 1.91
LINCOSAMIDES 206 0.63 268.84 0.78 90 0.52 117.29 0.60 94 0.25 125.01 0.38 194 0.69 252.63 0.72
clindamycin 206 100.00 268.84 100.00 90 100.00 117.29 100.00 94 100.00 125.01 100.00 194 100.00 252.63 100.00
TOTAL 32798 34364.26 17176 19687.22 37178 33096.95 28062 35202.57
DDD avg. in $ 1.04 1.14 0.89 1.25
Drugs total 193848.07 17.73 106904.55 18.42 188420.27 17.57 247422.94 14.23
Prescriptions total 28415 15579 28245 36250
Prescriptions avg. in $ 6.82 6.80 6.70 6.82
one hand and their high share in overall
drug consumption on the other hand. In
1998 systemic antibiotics accounted for
8.5% of the 21,405 million US$ worth
world drug market. The individual shares
of the European, North American, Aus-
tralian/African/Asian (A/A/A) and South
American markets were 27.7, 34.7, 27.5
and 10.1%, respectively1.
Patients and Methods
The study was conducted in four phar-
macies in Zagreb providing services for
approximately 20,000 clients, most of
whom obtain their health care from 8 pri-
mary care practices. Four groups of pre-
scriptions were analyzed, i.e. a total of
108,489 prescriptions given by primary
461
D. Mandi} et al.: Antibiotic Prescription in Ambulatory Care, Coll. Antropol. 25 (2001) 2: 459–465









































Fig. 2. Oral antibiotic consumption in Zagreb in 1999 expressed in US$.
care physicians in 1999, amounting to an
annual average of 5.4 prescription per pa-
tient (Table 1). The use of oral antibiotics
in comparison with total drug consump-
tion, the share of individual subclasses of
oral antibiotics and the respective shares
of individual products were also analyzed
(Figures 1 and 2). The data collected were
expressed in terms of both the defined
daily doses (DDD) and US$2. The results
obtained were estimated by comparing
the respective prescription rates of par-
ticular antibiotic classes or individual
agents against the guidelines for the ra-
tional use of drugs in outpatient clinics2.
Furthermore, they were compared with
available national and international da-
ta1,3–5.
In addition to oral antibiotics, the ana-
lysis included co – trimoxazole as the only
widely prescribed oral anti – infective
agent.
To reject the impact of changes in drug
prices, especially those resulting from the
exemption of drugs from the VAT system,
the drug prices in KN and the mean ex-
change rates valid on 31st December 1999
(1$ = 7.647 KN) were used in all calcula-
tions.
462
D. Mandi} et al.: Antibiotic Prescription in Ambulatory Care, Coll. Antropol. 25 (2001) 2: 459–465
TABLE 2
ORAL ANTIBIOTIC CONSUMPTION IN ZAGREB IN 1999
DDD %DDD $ %$
Penicilins 66284 57.53 54808.05 44.80
Benzylpenicillin 12734 19.21 6085.79 11.10
Ampicillin 437 0.66 253.67 0.46
Amoxicillin 28445 42.91 10030.79 18.30
Amox/clavul. Acid 24668 37.22 38437.80 70.13
Cephalosporins 14343 12.45 32058.85 26.20
Cephalexin 9122 63.53 12118.23 37.80
Cefuroxime axetil 3631 25.32 15194.20 47.39
Ceftibuten 1600 11.16 4746.42 14.81
Macrolides 8285 7.19 21578.12 17.64
Erytromycin 776 9.37 725.45 3.36
Azytromycin 7509 90.63 20852.67 96.64
Tetracyclines 9424 8.18 1232.27 1.01
Doxycycline 9424 1232.27
Quinolones 7622 6.62 9415.96 7.70
Norfloxacin 6960 91.31 7966.89 84.61
Ciprofloxacin 212 2.78 651.18 6.92
Pefloksacin 450 5.90 797.89 8.47
Co-trimoxazole 8672 7.53 2493.97 2.04
Lincosamides 584 0.51 763.76 0.62
Clindamycin 584 763.76
Total 115214 100.00 122350.99 100.00
Drugs total 736596 16.61%
Prescriptions total 108489
Results
Oral antibiotics account for 16.61% of
the overall drug consumption in financial
terms. In terms of DDD, penicillin’s ac-
count for 57.53%, cephalosporins for
12.45%, tetracyclines for 8.18%, co – tri-
moxazole for 7.53%, macrolides for 7.19%,
quinolones for 6.62% and lincosamides
for 0.51% of the total consumption (Table 2,
Figure 3).
When expressed in monetary terms,
the shares of individual antibiotic Gasses
produce a completely different picture:
penicillins account for 44.8D%, cephalo-
sporins for 26.2D%, macrolides for 17.64%,
quinolones for 7.70% co-trimoxazole for
2.04%, tetracyclines for 1.01%, and lin-
cosamides for 0.62% of the total consump-
tion (Table 2 and Figure 2).
Analysis by individual antibiotic indi-
cated that 4 major products accounted for
67.39% of the oral antibiotic market in
monetary terms and 38% of the market in
terms of DDD: amoxicillin/clavulanic acid
(Klavocin®) with a share of 31.42%, ce-
furoxime axetil (Novocef®) with 12.42%,
azythromycin (Sumamed®) with 17% and
norfloxacin (Nolicin®) with 6.51% (Figure 2).
Analysis by prescription group reveal-
ed differences in the prescribing practices
of individual physicians (Table 1). For a
reliable conclusion, each group of pre-
scriptions should be assigned relevant in-
formation about specific indications and
susceptibility data from appropriate bac-
teriological studies. The analysis indica-
ted that two packages sufficing for a 10 –
day course of treatment were prescribed
in 80% of cases.
Discussion
The results of the study demonstrated
a high share of oral antibiotics in the
overall drug consumption in ambulatory
care in the city of Zagreb. These findings
are consistent with the data published by
IMS, currently the only organized system
of drug consumption monitoring in Cro-
atia6. A similar research conducted in
France in 1996 revealed a significantly
lower share of 7.7% total drug market in
France7.
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Fig. 3. Oral antibiotic consumption in Zagreb in 1999 expressed in DDD.
Systemic antibiotics account for 8.5%
of the world pharmaceutical market and
oral antibiotics for 66.4% of this figure,
i.e. for 5.6% of the world market1. Analy-
sis of drug consumption by antibiotic
class revealed a significant difference be-
tween data expressed in terms of DDD
and in US$ (Figures 2 and 3). The results
obtained pointed to the frequent use of
new and relatively expensive oral antibi-
otics in ambulatory care.
The four leading classes of antibiotics
worldwide, i.e. penicillins, cephalosporins,
macrolides and quinolones, have approxi-
mately equal shares in the world drug
market (Figure 1). In the Zagreb area
penicillins are significantly more often
prescribed than either the macrolides or
especially the quinolones (Table 2 and
Figure 1).
Analysis by individual antibiotic indi-
cated that the world's leading oral antibi-
otics, i.e. amoxicillin/clavulanic acid, ce-
furoxime axetil and azythromycin, had
equally high shares in the overall drug
consumption in Croatia, presumable be-
cause these products are manufacture lo-
cally by Pliva, Zagreb. Quinolones, except
for norfloxacin, are somewhat less widely
prescribed because they are not available
on GP prescription. The serious economic
problems faced by post-war Croatia have
limited the use of imported drugs, espe-
cially when appropriate domestic alter-
natives were available.
In international terms the newer and
more expensive oral antibiotics are more
frequently used in developed Western
European and North American countries,
with quinolones and macrolides account-
ing for 68 arid 75% of the overall con-
sumption worldwide. In less developed
A/A/A and Latin American countries peni-
cillins and first – generation cephalospo-
rins are more widely prescribed, with co –
trimoxazole and chloramphenicol account-
ing for 65 and 93% of the overall con-
sumption worldwide1,3–5.
While definitely not aiming at the
level and quality of South American anti-
biotic prescription practices, Croatia still
has to decide whether it can afford – in
view of the current economic situation
and heavily restricted health care budget
– to adopt the high standards of modern
Europe.
Analysis of prescriptions by primary
care practice and pharmacy yielded the
following pattern of antibiotic usage:
among the penicillins as the most often
prescribed group of oral antibiotics the
number of prescriptions for amoxicillin
and amoxicillin/clavulanic acid was ap-
proximately the same in two pharmacies,
while ire the other two pharmacies either
amoxicillin or amoxicillin/clavulanic acid
Were significantly more often prescribed
than other drugs (57.3% vs. 25.71% and
27.73% vs. 54.33%, respectively). A simi-
lar pattern was observed in the consump-
tion of other newer and more expensive
oral antibiotics, i.e. cefuroxime axetil, cef-
tibuten and azythromycin (Table 1).
Since all the four pharmacies studied
are located in similar socio – economic en-
vironments in a relatively narrow geo-
graphic area, it is reasonable to assume
that the differences observed are due to
different prescribing practices of individ-
ual physicians rather than actual differ-
ences in indications, causative agents or
relevant antibiotic susceptibility patterns.
Of course, further research is needed to
obtain a definite conclusion.
The results obtained stress the need
for urgent reform the existing pharma-
ceutical sector in terms of both imple-
mentation of clinical and pharmaceutical
guidelines, introduction of cost-control
mechanisms based on sound and avail-
able evidence – based findings and cost
effectiveness standards.
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Furthermore, our study findings stress
the need to stimulate both rational pre-
scribing behavior of physicians in pri-
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PROPISIVANJE ORALNIH ANTIBIOTIKA U AMBULANTNOJ PRAKSI U
1999. GODINI – DOPRINOS RAZVOJU METODA ZA PRA]ENJE I
NADZOR POTRO[NJE I PROPISIVANJA LIJEKOVA
S A @ E T A K
Istra`ivanje je provedeno u cilju utvr|ivanja potro{nje antibiotika u ambulantnoj
praksi. Analizirana je potro{nja peroralnih antibiotika u ~etiri ljekarne u Zagrebu u
tijeku 1999. godine. Rezultati su prikazani u DDD-ima (definirane dnevne doze) i US$
te uspore|eni s dostupnim nacionalnim i me|unarodnim podacima. Istra`ivanje je po-
kazalo visoko u~e{}e peroralnih antibiotika u odnosu na ukupnu potro{nju lijekova,
posebno novih i skupih antibiotika unutar pojedinih grupa antibiotika. Za procjenu
opravdanosti takvog propisivanja, posebno s obzirom na ekonomsku situaciju u zdrav-
stvu Hrvatske, potrebno je provesti dodatna istra`ivanja.
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mary care, which is aimed at controlling
the demand side of the antibiotic market,
and to introduce mechanisms, which will
stimulate the supply side of the market to
reimburse drugs based on sound clinical
and efficacy criteria.
